IL‐18 pathway can be blocked by targeting IL‐18 with two drugs (GSK1070806, MEDI‐2338) in clinical trials positioned for Diabetes mellitus and COPD respectively. This evidence concerns the gene IL18 and chronic obstructive pulmonary disease.